Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-2-10
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1476-5551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
467-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19847200-Adult, pubmed-meshheading:19847200-Aged, pubmed-meshheading:19847200-Aminoglycosides, pubmed-meshheading:19847200-Antibodies, Monoclonal, pubmed-meshheading:19847200-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19847200-Antineoplastic Agents, pubmed-meshheading:19847200-Female, pubmed-meshheading:19847200-Humans, pubmed-meshheading:19847200-Karyotyping, pubmed-meshheading:19847200-Leukemia, Myeloid, Acute, pubmed-meshheading:19847200-Male, pubmed-meshheading:19847200-Middle Aged, pubmed-meshheading:19847200-Mutation, pubmed-meshheading:19847200-Neoplasm Recurrence, Local, pubmed-meshheading:19847200-Nuclear Proteins, pubmed-meshheading:19847200-Prognosis, pubmed-meshheading:19847200-Salvage Therapy, pubmed-meshheading:19847200-Tandem Repeat Sequences, pubmed-meshheading:19847200-Treatment Outcome, pubmed-meshheading:19847200-Young Adult, pubmed-meshheading:19847200-fms-Like Tyrosine Kinase 3
pubmed:year
2010
pubmed:articleTitle
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
pubmed:publicationType
Letter